Abstract
The rat Nb2 lymphoma is useful for studying prolactin (PRL) receptor signaling to mitogenesis and apoptosis suppression. Previous results showed that PRL rapidly induced expression of several apoptosis suppressor genes during the G1 phase of cell cycle in this model. The X-linked inhibitor of apoptosis protein (XIAP) gene product acts to suppress apoptosis by direct inhibition of caspases. The present study was conducted to determine whether PRL alters XIAP expression in lactogen-dependent Nb2-11 or-independent Nb2-SFJCD1 cells. Stationary Nb2-11 cultures expressed detectable levels of an 8.9-kb XIAP transcript. PRL (20 ng/mL) stimulated its expression, reaching maximal levels within 12h. Expression of XIAP was also evaluated in Nb2-SFJCD 1 cells subsequent to treatment with differentiating agents (sodium butyrate [2 mM, 72 h], all trans-retinoic acid [10 μM, 72 h], or 1,25-dihydroxycholecalciferol [100 nM, 24 h]. PRL significantly increased XIAP expression in cells previously treated with these compounds. Further analysis revealed that PRL stimulated XIAP expression during S phase of the cell cycle. To determine whether XIAP suppressed apoptosis, its cDNA was stably transfected into Nb2-11 cells. Compared to controls, cells coverexpressing XIAP exhibited substantially less DNA fragmentation when apoptosis was induced by PRL deprivation or glucocorticoids. We conclude that PRL-stimulated XIAP expression likely serves to suppress apoptosis as cells progress through the later phases of the cell cycle.
Similar content being viewed by others
References
Gout, P. W., Beer, C. T., and Noble, R. L. (1980). Cancer Res. 40, 2433–2436.
Fleming, W. H., Pettigrew, N. M., Matusik, R. J., and Freisen, H. G. (1982). Cancer Res. 42, 3138–3141.
Cox, J. H., Lamb, J. R., Bal, V., Butcher, G. W., Howard, J. C., Owen, M. J., and Ivanyi, J. (1989). J. Immunol. 66, 83–89.
Richards, J. F., Beer, C. T., Bourgeault, C., Chen, K., and Gout, P. W., (1982). Mol. Cell Endocrinol. 26, 41–49.
Fletcher-Chiappini, S. E., Compton, M. M., LaVoie, H. A., Day, E. B., and Witorsch, R. J. (1993). Proc. Soc. Exp. Biol. Med. 202, 345–352.
Witorsch, R. J., Day, E. B., LaVoie, H. A., Hashemi, N., and Taylor, J. K. (1993). Proc. Soc. Exp. Biol. Med. 203, 454–460.
LaVoie, H. A. and Witorsch, R. J. (1995). Proc. Soc. Exp. Biol. Med. 209, 257–269.
Krumenacker, J. S., Buckley, D. J., Leff, M. A., McCormack, J. T., de Jong, G., Gout, P. W., Reed, J. C., Miyashita, T., Magnuson, N. S., and Buckley, A. R. (1998). Endocrine 9(2), 163–170.
Gout, P. W. (1987). Cancer. Res. 47, 1751–1755.
Zhang, M., Blake, M. J., Gout, P. W., Buckley, D. J., and Buckley, A. R. (1999). Cell Growth Differ. 10, 759–767.
Leff, M. A., Buckley, D. J., Krumenacker, J. S., Reed, J. C., Miyashita, T., and Buckley, A. R. Endocrinology 137, 5456–5462.
Hockenbery, D. M. (1992). Semin. Immunol. 4(6), 413–420.
Moroy, T., Grzeschiczek A., Petzold, S., and Hartmann, K. U. (1993). Proc. Natl. Acad. Sci. USA 90, 10,743–10,738.
Buckley, A. R., Buckley, D. J., Leff, M. A., Hoover, D. S., and Magnuson, N. S. (1995). Endocrinology 136, 5252–5259.
Duckett, C. S., Nava, V. E., Gedrich, R. W., Clem, R. J., Van Dogen, J. L., Gilfillan, M. C., Shiels, H., Hardwick, J. M., and Thompson, C. B. (1996). EMBO J. 15, 2685–2694.
Clem, R. J., Fechheimer, M., and Miller, L. K. (1991). Science 254, 1388–1390.
Clem, R. J. and Miller, L. K. (1994). Mol. Cell. Biol. 14, 3212–3222.
Deveraux, Q. L., Takahashi, R., Salvesen, G. S., and Reed, J. C. (1997). Nature 388, 300–303.
Deveraux, Q. L., Leo, E., Stennicke, H. R., Welsh, K., Salvesen, G. S., and Reed, J. C. (1999). EMBO J. 18(19), 5242–5241.
Wagenknecht, B., Glaser, T., Naumann, U., Kugler, S., Isenmann, S., Bahr, M., Korneluk, R., Liston, P., and Weller, M. (1999). Cell Death Differ. 6(4), 370–376.
Buckley, A. R., Leff, M. A., Buckley, D. J., Magnuson, N. S., de Jong, G., and Gout, P. W. (1996). Cell Growth Differ. 7, 1713–1721.
Imaizumi, M., and Breitman, T. R. (1987). Eur. J. Haematol. 38(4), 289–302.
Leung, M. F. and Wong, K. F. (1999). J. Hematother. 8(3), 275–279.
Miyaura, C., Abe, E., Kuribayashi, T., Tanaka, H., Konno, K., Nishi, Y., and Suda, T. (1981). Biochem. Biophys. Res. Commun. 102(3), 937–943.
Pedrali-Noy, G. and Spadari, S. (1979). Biochem. Biophys. Res. Commun. 88, 1194–2002.
Ikegami, S., Taguchi, T., Ohashi, M., Nagano, H., and Mano, Y. (1978). Nature 275(5679), 458–460.
Hubscher, U., Kuenzle, C. C., Limacher, W., Sherrer, P., and Spadari, S. (1979). Cold Spring Harbor Symp. Quant. Biol. 439(1), 625–629.
Datta, R., Oki, E., Endo, K., Biedermann, V., Ren, J., and Kufe, D. (2000). J. Biol. Chem. 275(41), 31,733–31,738.
Borden, K. L. (1998). Biochem. Cell. Biol. 76, 351–358.
Sun, C., Cai, M., Gunasekara, A. H., Meadows, R. P., Wang, H., Chen, J., Zhang, H., Wu, W., Xu, N., Ng, S. C., and Fesik, S. W. (1999). Nature 401(6755), 818–822.
Stehlik, C., de Martin, R., Kumabashiri, I., Schmid, J. A., Binder, B. R., and Lipp, J. (1998). J. Exp. Med. 188(1), 211–216.
Hofer-Warbinek, R., Schmid, J. A., Stehlik, C., Binder, B. R., Lipp, J., and de Martin, R. (2000). J. Biol. Chem. 275, 22,064–22,068.
Kawakami, A., Nakashiman, T., Sakai, H., Urayama, S., Yamasaki, S., Hida, A., Tsuboi, M., Nakamura, H., Ida, H., Migita, K., Kawabe, Y., and Eguchi, K. (1999). Blood 94(11), 3847–3854.
Zhang, H. G., Huang, N., Liu, D., Bilbao, L., Zhang, X., Yang, P., Zhou, T., Curiel, D. T., and Mountz, J. D. (2000). Arthritis Rheum. 43(5), 1094–1105.
Sonoda, Y., Matsumoto, Y., Funakoshi, M., Yamamoto, D., Hanks, S. K., and Kasahara, T. (2000). J. Biol. Chem. 275(21), 16,309–16,315.
Asselin, E., Mills, G. B., and Tsang, B. K. (2001). Cancer Res. 61, 1862–1868.
Krumenacker, J. S., Narang, V. S., Buckley, D. J., and Buckley, A. R. (2001). J. Neuroimmunol. 113, 249–259.
Tran, J., Rak, J., Sheehan, C., Saibil, S. D., LaCasse, E., Korneluk, R. G., and Kerbel, R. S. (1999). Biochem. Biophys. Res. Commun. 264(3), 781–788.
Gum, J. R., Kam, W. K., Byrd, J. C., Hicks, J. W., Sleisenger, M. H., and Kim, Y. S. (1987). J. Biol. Chem. 262, 1092–1097.
Tamm, I., Kornblau, S. M., Segall, H., Krajewski, S., Welsh, K., Kitada, S., Scudiero, D. A., Tudor, G., Qui, Y. H., Monks, A., Andreeff, M., and Reed, J. C. (2000). Clin. Cancer Res. 6(5), 1796–1803.
Piedrafita, F. J. and Pfahl, M. (1997). Mol. Cell. Biol. 17, 6348–6358.
Kobayashi, K., Hatano, M., Otaki, M., Ogasawara, T., and Tokuhisa, T. (1999). Dev. Biol. 96(4), 1457–1462.
Gout, P. W., Beer, C. T., and Noble, R. L. (1980). Cancer Res. 40, 2433–2436.
Clevenger, C. V., Thickman, K., Ngo, W., Chang, W., Takayama, S., and Reed, J. C. (1997). Mol. Endocrinol. 11(5), 608–618.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krishnan, N., Buckley, D.J., Zhang, M. et al. Prolactin-stimulated X-linked inhibitor of apoptosis protein expression during S phase cell cycle progression in rat Nb2 lymphoma cells. Endocr 15, 177–186 (2001). https://doi.org/10.1385/ENDO:15:2:177
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:15:2:177